Skip to content

Clinical trials

Phase 3 Hepatitis C trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: France Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20061
20073
20082
20093
20101
201110
201212
20134
20143
20156
20175
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb12
Gilead Sciences10
Janssen R&D Ireland6
AbbVie5
GlaxoSmithKline4
Debiopharm International SA3
French National Agency for Research on AIDS and Viral Hepatitis3
Boehringer Ingelheim2
Human Genome Sciences Inc.2
Janssen-Cilag International NV2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C56
Hepatitis C, Chronic17
Fibrosis5
Hepatitis5
Bronchiolitis Obliterans Syndrome3
Liver Diseases3
Thrombocytopenia2
Virus Diseases2
Acquired Immunodeficiency Syndrome1
Digestive System Diseases1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.